Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial

Piperacillin/tazobactam was compared with ceftazidime for the empirical treatment of febrile neutropenia in patients with acute leukemia or following autologous peripheral blood stem cell transplantation. Owing to inclusion criteria, it was possible for the same patient to be randomized several time...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harter, Christoph (VerfasserIn) , Schulze, Birte (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Benner, Axel (VerfasserIn) , Geiss, Heinrich K. (VerfasserIn) , Hoppe-Tichy, Torsten (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Egerer, Gerlinde (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 9 January 2006
In: Bone marrow transplantation
Year: 2006, Jahrgang: 37, Heft: 4, Pages: 373-379
ISSN:1476-5365
DOI:10.1038/sj.bmt.1705256
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.bmt.1705256
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1705256
Volltext
Verfasserangaben:C. Harter, B. Schulze, H. Goldschmidt, A. Benner, H.K. Geiss, T. Hoppe-Tichy, A.D. Ho and G. Egerer

MARC

LEADER 00000caa a2200000 c 4500
001 1776273281
003 DE-627
005 20230428085620.0
007 cr uuu---uuuuu
008 211105s2006 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.bmt.1705256  |2 doi 
035 |a (DE-627)1776273281 
035 |a (DE-599)KXP1776273281 
035 |a (OCoLC)1341423415 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Harter, Christoph  |d 1969-  |e VerfasserIn  |0 (DE-588)133944816  |0 (DE-627)558825788  |0 (DE-576)278400159  |4 aut 
245 1 0 |a Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation  |b a prospective randomized trial  |c C. Harter, B. Schulze, H. Goldschmidt, A. Benner, H.K. Geiss, T. Hoppe-Tichy, A.D. Ho and G. Egerer 
246 3 0 |a versus 
264 1 |c 9 January 2006 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.11.2021 
520 |a Piperacillin/tazobactam was compared with ceftazidime for the empirical treatment of febrile neutropenia in patients with acute leukemia or following autologous peripheral blood stem cell transplantation. Owing to inclusion criteria, it was possible for the same patient to be randomized several times. A total of 219 individual patients were admitted to a prospective randomized clinical study: 24 patients were included twice. Patients (23.5%) remained afebrile. Patients who developed febrile neutropenia were randomized to receive intravenous ceftazidime (n=74 patients, group I) or piperacillin/tazobactam (n=87 patients, group II). Response to first-line antibiotic treatment was seen in 55% (group I) and 53% (group II). After the addition of vancomycin, a further 19% (group I) and 24% (group II) of the patients became afebrile. Causes of fever were: microbiologically documented infection in 36 and 34 patients of group I and II; Clostridium difficile in eight and 12 patients of group I and II, and fever of unknown origin in 30 and 41 patients of group I and II. One patient died in each group. Single-agent therapy with piperacillin/tazobactam is as effective as ceftazidime in the treatment of neutropenic fever and is well tolerated. Direct and indirect costs of both treatment regimes are equivalent. 
650 4 |a Cell Biology 
650 4 |a general 
650 4 |a Hematology 
650 4 |a Internal Medicine 
650 4 |a Medicine/Public Health 
650 4 |a Public Health 
650 4 |a Stem Cells 
700 1 |a Schulze, Birte  |d 1979-  |e VerfasserIn  |0 (DE-588)140954597  |0 (DE-627)623699826  |0 (DE-576)321520335  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Geiss, Heinrich K.  |d 1952-  |e VerfasserIn  |0 (DE-588)172094127  |0 (DE-627)697004988  |0 (DE-576)132967464  |4 aut 
700 1 |a Hoppe-Tichy, Torsten  |e VerfasserIn  |0 (DE-588)1095801376  |0 (DE-627)856418919  |0 (DE-576)467814597  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Egerer, Gerlinde  |e VerfasserIn  |0 (DE-588)105502168X  |0 (DE-627)792516745  |0 (DE-576)167430882  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 37(2006), 4, Seite 373-379  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation a prospective randomized trial 
773 1 8 |g volume:37  |g year:2006  |g number:4  |g pages:373-379  |g extent:7  |a Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation a prospective randomized trial 
856 4 0 |u https://doi.org/10.1038/sj.bmt.1705256  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/1705256  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211105 
993 |a Article 
994 |a 2006 
998 |g 105502168X  |a Egerer, Gerlinde  |m 105502168X:Egerer, Gerlinde  |d 910000  |d 910100  |e 910000PE105502168X  |e 910100PE105502168X  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1095801376  |a Hoppe-Tichy, Torsten  |m 1095801376:Hoppe-Tichy, Torsten  |d 910000  |e 910000PH1095801376  |k 0/910000/  |p 6 
998 |g 172094127  |a Geiss, Heinrich K.  |m 172094127:Geiss, Heinrich K.  |d 910000  |d 911700  |e 910000PG172094127  |e 911700PG172094127  |k 0/910000/  |k 1/910000/911700/  |p 5 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 4 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |d 50000  |e 910000PG102258023X  |e 910100PG102258023X  |e 50000PG102258023X  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 140954597  |a Schulze, Birte  |m 140954597:Schulze, Birte  |d 50000  |e 50000PS140954597  |k 0/50000/  |p 2 
998 |g 133944816  |a Harter, Christoph  |m 133944816:Harter, Christoph  |d 910000  |d 910100  |e 910000PH133944816  |e 910100PH133944816  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1776273281  |e 3999378131 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"role":"aut","given":"Christoph","display":"Harter, Christoph","family":"Harter"},{"display":"Schulze, Birte","family":"Schulze","given":"Birte","role":"aut"},{"role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"display":"Benner, Axel","family":"Benner","role":"aut","given":"Axel"},{"given":"Heinrich K.","role":"aut","display":"Geiss, Heinrich K.","family":"Geiss"},{"given":"Torsten","role":"aut","display":"Hoppe-Tichy, Torsten","family":"Hoppe-Tichy"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"},{"given":"Gerlinde","role":"aut","display":"Egerer, Gerlinde","family":"Egerer"}],"relHost":[{"recId":"320433366","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2004030-1"],"issn":["1476-5365"],"eki":["320433366"]},"title":[{"title_sort":"Bone marrow transplantation","title":"Bone marrow transplantation"}],"pubHistory":["Nachgewiesen 19.1997 -"],"origin":[{"publisherPlace":"London ; Basingstoke ; London","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedKey":"1997","dateIssuedDisp":"1997-"}],"note":["Gesehen am 17.01.25"],"disp":"Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation a prospective randomized trialBone marrow transplantation","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"issue":"4","text":"37(2006), 4, Seite 373-379","pages":"373-379","year":"2006","volume":"37","extent":"7"}}],"recId":"1776273281","name":{"displayForm":["C. Harter, B. Schulze, H. Goldschmidt, A. Benner, H.K. Geiss, T. Hoppe-Tichy, A.D. Ho and G. Egerer"]},"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1038/sj.bmt.1705256"],"eki":["1776273281"]},"note":["Gesehen am 05.11.2021"],"origin":[{"dateIssuedKey":"2006","dateIssuedDisp":"9 January 2006"}],"title":[{"title":"Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation","title_sort":"Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation","subtitle":"a prospective randomized trial"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a HARTERCHRIPIPERACILL9200